Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

[Enzyme therapy in the treatment of lymphedema in the arm after breast carcinoma surgery].

Identifieur interne : 005016 ( PubMed/Curation ); précédent : 005015; suivant : 005017

[Enzyme therapy in the treatment of lymphedema in the arm after breast carcinoma surgery].

Auteurs : J. Adámek [République tchèque] ; J. Prausová ; M. Wald

Source :

RBID : pubmed:9265253

Descripteurs français

English descriptors

Abstract

The authors evaluate the contribution of proteolytic enzymes used in the treatment of the lymphatic oedema of the arm after mastectomy and radiotherapy for breast cancer. Proteolytic enzymes were successfully administered in monotherapy of lymphatic oedema as well as supportive therapy in other therapeutically ways.

PubMed: 9265253

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:9265253

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">[Enzyme therapy in the treatment of lymphedema in the arm after breast carcinoma surgery].</title>
<author>
<name sortKey="Adamek, J" sort="Adamek, J" uniqKey="Adamek J" first="J" last="Adámek">J. Adámek</name>
<affiliation wicri:level="3">
<nlm:affiliation>Chirurgická klinika FN Motol, Praha.</nlm:affiliation>
<country>République tchèque</country>
<placeName>
<settlement type="city">Prague</settlement>
<region type="région" nuts="2">Bohême centrale</region>
</placeName>
<wicri:orgArea>Chirurgická klinika FN Motol</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Prausova, J" sort="Prausova, J" uniqKey="Prausova J" first="J" last="Prausová">J. Prausová</name>
</author>
<author>
<name sortKey="Wald, M" sort="Wald, M" uniqKey="Wald M" first="M" last="Wald">M. Wald</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1997">1997</date>
<idno type="RBID">pubmed:9265253</idno>
<idno type="pmid">9265253</idno>
<idno type="wicri:Area/PubMed/Corpus">005016</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005016</idno>
<idno type="wicri:Area/PubMed/Curation">005016</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005016</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">[Enzyme therapy in the treatment of lymphedema in the arm after breast carcinoma surgery].</title>
<author>
<name sortKey="Adamek, J" sort="Adamek, J" uniqKey="Adamek J" first="J" last="Adámek">J. Adámek</name>
<affiliation wicri:level="3">
<nlm:affiliation>Chirurgická klinika FN Motol, Praha.</nlm:affiliation>
<country>République tchèque</country>
<placeName>
<settlement type="city">Prague</settlement>
<region type="région" nuts="2">Bohême centrale</region>
</placeName>
<wicri:orgArea>Chirurgická klinika FN Motol</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Prausova, J" sort="Prausova, J" uniqKey="Prausova J" first="J" last="Prausová">J. Prausová</name>
</author>
<author>
<name sortKey="Wald, M" sort="Wald, M" uniqKey="Wald M" first="M" last="Wald">M. Wald</name>
</author>
</analytic>
<series>
<title level="j">Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti</title>
<idno type="ISSN">0035-9351</idno>
<imprint>
<date when="1997" type="published">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Arm</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Drug Combinations</term>
<term>Female</term>
<term>Humans</term>
<term>Hydrolases (therapeutic use)</term>
<term>Lymphedema (drug therapy)</term>
<term>Lymphedema (etiology)</term>
<term>Mastectomy (adverse effects)</term>
<term>Rutin (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Association médicamenteuse</term>
<term>Bras</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hydrolases (usage thérapeutique)</term>
<term>Lymphoedème (traitement médicamenteux)</term>
<term>Lymphoedème (étiologie)</term>
<term>Mastectomie (effets indésirables)</term>
<term>Rutoside (usage thérapeutique)</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (radiothérapie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Hydrolases</term>
<term>Rutin</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Drug Combinations</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Mastectomy</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Mastectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr">
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Hydrolases</term>
<term>Rutoside</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Arm</term>
<term>Female</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Association médicamenteuse</term>
<term>Bras</term>
<term>Femelle</term>
<term>Humains</term>
<term>Tumeurs du sein</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The authors evaluate the contribution of proteolytic enzymes used in the treatment of the lymphatic oedema of the arm after mastectomy and radiotherapy for breast cancer. Proteolytic enzymes were successfully administered in monotherapy of lymphatic oedema as well as supportive therapy in other therapeutically ways.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">9265253</PMID>
<DateCreated>
<Year>1997</Year>
<Month>08</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>1997</Year>
<Month>08</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised>
<Year>2016</Year>
<Month>12</Month>
<Day>06</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0035-9351</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>76</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1997</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti</Title>
<ISOAbbreviation>Rozhl Chir</ISOAbbreviation>
</Journal>
<ArticleTitle>[Enzyme therapy in the treatment of lymphedema in the arm after breast carcinoma surgery].</ArticleTitle>
<Pagination>
<MedlinePgn>203-4</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The authors evaluate the contribution of proteolytic enzymes used in the treatment of the lymphatic oedema of the arm after mastectomy and radiotherapy for breast cancer. Proteolytic enzymes were successfully administered in monotherapy of lymphatic oedema as well as supportive therapy in other therapeutically ways.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Adámek</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Chirurgická klinika FN Motol, Praha.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Prausová</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wald</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>cze</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Enzymoterapie v lécbĕ lymfedému paze po operaci pro karcinom prsu.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Czech Republic</Country>
<MedlineTA>Rozhl Chir</MedlineTA>
<NlmUniqueID>9815441</NlmUniqueID>
<ISSNLinking>0035-9351</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>5G06TVY3R7</RegistryNumber>
<NameOfSubstance UI="D012431">Rutin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>72506-65-1</RegistryNumber>
<NameOfSubstance UI="C023295">Wobenzym</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.-</RegistryNumber>
<NameOfSubstance UI="D006867">Hydrolases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D001132" MajorTopicYN="Y">Arm</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006867" MajorTopicYN="N">Hydrolases</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008408" MajorTopicYN="N">Mastectomy</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012431" MajorTopicYN="N">Rutin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1997</Year>
<Month>4</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1997</Year>
<Month>4</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1997</Year>
<Month>4</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">9265253</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005016 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 005016 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:9265253
   |texte=   [Enzyme therapy in the treatment of lymphedema in the arm after breast carcinoma surgery].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:9265253" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024